Stable Nanoemulsions for the Delivery of Small Molecule Immune Potentiators
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 107 (9) , 2310-2314
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Towards an evidence based approach for the development of adjuvanted vaccinesCurrent Opinion in Immunology, 2017
- Strategies for designing synthetic immune agonistsImmunology, 2016
- Toll‐like receptors: the swiss army knife of immunity and vaccine developmentClinical & Translational Immunology, 2016
- TLR4/MD-2 activation by a synthetic agonist with no similarity to LPSProceedings of the National Academy of Sciences, 2016
- Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR AgonistsCurrent Medicinal Chemistry, 2015
- Are innate immune signaling pathways in plants and animals conserved?Nature Immunology, 2005
- Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and ImiquimodCellular Immunology, 1999
- A human homologue of the Drosophila Toll protein signals activation of adaptive immunityNature, 1997
- The Dorsoventral Regulatory Gene Cassette spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila AdultsCell, 1996
- Cytokine induction by the immunomodulators imiquimod and S-27609Journal of Leukocyte Biology, 1995